ATAI

News Atai Life Sciences Revenue Jumps 163%

14d ago

News Psychedelic Stocks Trip Up After FDA Advisors Reject MDMA For PTSD Treatment

14d ago

Short volume Short volume 66% of volume (3.0σ)

28d ago

Insider trade Sale by Kevin James Craig (Chief Medical Officer)

38d ago

Insider trade Sale by Kevin James Craig (Chief Medical Officer)

40d ago

News Cybin stands out as the most undervalued psychedelic stock as Trump signs on faster PTSD research

43d ago

News Psychedelic stocks rally after Trump orders faster PTSD research; Compass Pathways, Atai lead gains

43d ago

News AtaiBeckley weighing options for lead psychedelic therapy: Bloomberg

86d ago

News AtaiBeckley Participates in the 64th Annual ACNP Meeting with Two Scientific Poster Presentations and Hot Topic Presentation

137d ago

Scanner Unusual volume (z=7.5)

160d ago

Scanner Unusual volume (z=7.4)

161d ago

Scanner Unusual volume (z=7.4)

163d ago

Scanner Unusual volume (z=7.4)

164d ago